The first personal-use exoskeleton for children
EXPLORER helps children with special needs walk with stability, mimicking natural movement and giving them the freedom to enjoy every step.
- An innovative solution that allows children to move freely in their daily lives
- Adapts to growth from ages 2 to 17*
- Mimics the function of natural muscles
- Safe technology validated through multiple clinical studies in collaboration with Niño Jesús Hospital, Gregorio Marañón Hospital, La Paz Hospital, and 12 de Octubre Hospital

DAY-TO-DAY
Allows children to carry out daily life activities
INCLUSIVE
A tool for inclusion, not just rehabilitation

HYBRID
The first personal device with an automatic seat
FAMILY LEISURE
Helps children enjoy entertainment moments with their family

Who can use EXPLORER?
The first pediatric personal-use exoskeleton specifically designed to assist walking in children with neurodevelopmental disorders.
- Age: 2 to 17 years.
- Weight: < 60 kg
- Hip width: ≤ 40cm
- Femur length: 21 to 36 cm
- Tibia length: de 20 to 35 cm
- EU shoe size: ≤ 40
About Marsi Bionics
Marsi Bionics was founded in 2013 as a spin-off from the Center for Automation and Robotics (CAR), a joint center between the Spanish National Research Council (CSIC) and the Polytechnic University of Madrid (UPM), transferring over 20 years of expertise in robotic locomotion.
Marsi Bionics' major achievement has been the development of the world’s first pediatric exoskeleton. There is no other technology like it, allowing 360º movement for children who cannot walk or have lost the ability to do so.
It is a 100% success story of knowledge transfer in Spain. It originated from public research (2009) with a deeply personal story: the parents of Daniela, a girl who became paraplegic after an accident, approached CSIC in search of a project that could help her walk. That was where the "first steps" of the exoskeleton began. Once the project was completed, with an initial prototype, Elena García Armada decided to create Marsi Bionics (2013) to bring the research results to society.
From 2013 to 2021, Marsi Bionics financed, developed, industrialized, conducted clinical research, and certified the device, which received CE marking from the Spanish Agency of Medicines and Medical Devices in May 2021. Today, distribution has already expanded both in Spain and internationally. This process marks the culmination of 8 years of knowledge transfer, from public research to hospitals and rehabilitation centers worldwide.
Marsi Bionics is already present with its devices across almost the entire national territory, in various types of centers: public hospitals, rehabilitation centers, and special education centers.
Additionally, our exoskeletons are also present in international centers, with notable presence in France, Mexico, Poland, Italy, and Ireland, while progress is being made towards future commercialization in the United States.
Our strong clinical evidence supports the effectiveness and safety of our devices, as well as their positive impact on the rehabilitation and mobility of children with neuromuscular conditions, improving their quality of life and independence.
Our team of specialists has extensive knowledge of robotics applied to walking, providing training, technical support, and continuous follow-up to all users of our devices.
Thanks to this combination of advanced technology, clinical backing, and comprehensive care, Marsi Bionics continues to expand its global presence, making mobility and rehabilitation accessible to an increasing number of children worldwide.
2025
- II AESLEME Juan García Reneses Award for Innovation in Assistive Technology or Rehabilitation. AESLEME
- National Police Award for Equality in the Extraordinary category. National Police
- Business Award from the Association of Entrepreneurs of Arganda, Rivas, and Comarca (ASEARCO) for the Most Innovative SME. ASEARCO
2024
- DHL Atlas Award for the Most Innovative Export. DHL Express Spain
2023
- Influential Award in the Science and Health category. El Confidencial
- National Disability Award Queen Letizia. Royal Board on Disability
- Engineering Mutuality Foundation Award. Engineering Mutuality Foundation
- March 8th Technology Award. Community of Madrid
- Most Innovative Project Award. Association of Family Businesses of Madrid
2022
- European Inventor of the Year. European Patent Office
- Gold Medal. Spanish Red Cross
- Fermina Orduña Research Award. Community of Madrid
2021
- Honorary Mention as Industrial Engineer of the Year. COIIM
- Beato de Liébana Award for International Cohesion. Government of Cantabria
- Ada Byron Award for Women in Technology. University of Deusto
2020
- Durán Farrell Award for Technological Research. UPC Social Council
2019
- Excellence Award for Women in Engineering. Talgo Foundation
- DISCAPNET Award. ONCE Foundation
2018
- Gold Medal of the City of Madrid. Madrid City Council
- Silver Plaque for Madrid Healthcare. Community of Madrid
2017
- FENIN 2017 Award for Entrepreneurship in Healthcare Technology. Spanish Federation of Healthcare Technology Companies
- Special Jury Award for Best Biomedical Researcher of the Year. A Tu Salud
2016
- ABC Health Award for Healthcare Technology of the Year
- Fuera de Serie-Volkswagen Award for Social Innovation
2015
- CEPYME 2015 Award for Best Entrepreneurial Project. Spanish Confederation of Small and Medium Enterprises
2014
- Passion>ie Award, Future Healthcare category. Accenture + IE Business School
- madri+d Award for the Best Technology-Based Business Idea. Madri+d Foundation
INTERNATIONAL
PRESENCE
More than 30 centers across Europe and Latin America
SCIENTIFIC
COMMITTEE
Composed of 14 members with extensive scientific careers
CLINICAL
STUDIES
Supporting the effectiveness of our devices
CLINICAL REHABILITATION
CENTER
For advanced physical therapy in clinical research
PROJECT FUNDED BY THE EUROPEAN MECHANISM FOR TRANSFORMATION AND RESILIENCE
Within the framework of R&D projects related to personalized medicine and Advanced Therapies under the joint ISCIII-CDTI initiative. Pending CE certification.



IN COLLABORATION WITH





